but is required for TCR–CD3 recycling to the cell surface. Notably, other IFT components are also expressed by T cells and participate in T cell activation as a complex with IFT20. So ...

(Nasdaq: TLSA) ("Tiziana” or the "Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ...